Kanaujia G V, Motzel S, Garcia M A, Andersen P, Gennaro M L
Public Health Research Institute, Newark, New Jersey. Merck Research Laboratories, West Point, Pennsylvania. Department of Comparative Medicine, Stanford University, Stanford, California Statens Serum Institute, Copenhagen, Denmark.
Clin Diagn Lab Immunol. 2004 Jan;11(1):222-6. doi: 10.1128/cdli.11.1.222-226.2004.
Previous work in our laboratory showed that the ESAT-6 protein of Mycobacterium tuberculosis and Mycobacterium bovis induces strong antibody responses in a large proportion ( approximately 90%) of experimentally or naturally infected nonhuman primates. Here, the antibody response to ESAT-6 in tuberculous monkeys was characterized at the epitope level by measuring antibodies to overlapping, synthetic peptides spanning the ESAT-6 sequence. The antibody response against the COOH-terminal portion of the protein was the strongest in both experimentally and naturally infected animals. Moreover, these antibodies became detectable the earliest during experimental infection, suggesting an ordered expansion of ESAT-6-specific B-cell clones in the course of infection. The data support use of synthetic peptides in lieu of the full-length ESAT-6 protein in diagnostic antibody detection assays.
我们实验室之前的研究表明,结核分枝杆菌和牛分枝杆菌的ESAT-6蛋白能在很大比例(约90%)的实验性或自然感染的非人灵长类动物中诱导强烈的抗体反应。在此,通过检测针对跨越ESAT-6序列的重叠合成肽的抗体,在表位水平对结核猴中ESAT-6的抗体反应进行了表征。在实验感染和自然感染的动物中,针对该蛋白COOH末端部分的抗体反应最强。此外,在实验感染期间,这些抗体最早可被检测到,这表明在感染过程中ESAT-6特异性B细胞克隆呈有序扩增。这些数据支持在诊断性抗体检测试验中使用合成肽代替全长ESAT-6蛋白。